Theravance Biopharma (TBPH) Change in Receivables (2013 - 2019)
Theravance Biopharma's (TBPH) quarterly Change in Receivables came in at -$86000.0 in Q4 2019, up 96.42% year-on-year from -$43783.1 in Q4 2018, and up 40.69% on a QoQ basis from -$145000.0 in Q3 2019.
Theravance Biopharma (TBPH) Change in Receivables (2013 - 2019) Analysis & Trends
Theravance Biopharma (TBPH) has 7 years of Change in Receivables data on file, last reported at -$86000.0 in Q4 2019.
- On a quarterly basis, Change in Receivables rose 96.42% year-over-year to -$86000.0 in Q4 2019; TTM through Dec 2019 was -$620000.0, a 62.03% increase from a year earlier, with the FY2019 full-year figure at -$620000.0, up 62.03% from the prior year.
- Change in Receivables for Q4 2019 stood at -$86000.0, up from -$145000.0 in the prior quarter.
- Over the last five years, Change in Receivables for TBPH reached as high as $1.5 million in Q2 2018 and fell as low as -$2.4 million in Q4 2018.
- Historically, Change in Receivables has averaged -$14450.0 across 5 years, with a median of $45500.0 in 2015.
- Across the five-year window, Change in Receivables plunged 4368.18% in 2016 and jumped 1192.92% in 2018, its largest moves.
- Year by year, Change in Receivables stood at $1.1 million in 2015, then sank by 119.93% to -$227000.0 in 2016, then soared by 398.24% to $677000.0 in 2017, then tumbled by 455.1% to -$2.4 million in 2018, then soared by 96.42% to -$86000.0 in 2019.
- Per Business Quant data, the three most recent Change in Receivables figures were -$86000.0 in Q4 2019, -$145000.0 in Q3 2019, and $118000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Theravance Biopharma | 864.56 Mn | 469.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -86,000.00 |
| Dec 31, 2019 | -86,000.00 |
| Sep 30, 2019 | -145,000.00 |
| Sep 30, 2019 | -145,000.00 |
| Jun 30, 2019 | 118,000.00 |
| Jun 30, 2019 | 118,000.00 |
| Mar 31, 2019 | -507,000.00 |
| Mar 31, 2019 | -507,000.00 |
| Dec 31, 2018 | -2.40 Mn |
| Dec 31, 2018 | -2.40 Mn |
| Sep 30, 2018 | -410,000.00 |
| Sep 30, 2018 | -410,000.00 |
| Jun 30, 2018 | 1.46 Mn |
| Jun 30, 2018 | 1.46 Mn |
| Mar 31, 2018 | -280,000.00 |
| Mar 31, 2018 | -280,000.00 |
| Dec 31, 2017 | 677,000.00 |
| Dec 31, 2017 | 677,000.00 |
| Sep 30, 2017 | 230,000.00 |
| Sep 30, 2017 | 230,000.00 |